Suzetrigine for hip fractures

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Oct 2026: Trial registered, NCT07905404

The trials

NCT07905404: Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture

State
Not started
Phase
Phase 4
People
79 planned
Started
5 Jan 2027
Primary completion
30 Jul 2028
Arms
Suzetrigine + Standard Multimodal Analgesia
Results
None posted
  1. 29 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Journavx, Suz, Suzetrigine (Journavx), Suzetrigine (SUZ), Suzetrigine Group, oral suzetrigine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.